Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Athersys stock in Canada | $1.67
Own Athersys shares in just a few minutes.
Athersys is a biotechnology business based in the US. Athersys stocks (ATHX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.5 – an increase of 2.45% over the previous week. Athersys employs 97 staff and has a trailing 12-month revenue of around $1.4 million.
How to buy Athersys stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ATHX in this case.
- Research Athersys stocks. The platform should provide the latest information available.
- Buy your Athersys stocks. It's that simple.
What's in this guide?
- Can I buy shares in Athersys?
- Has coronavirus impacted Athersys shares?
- Athersys shares summary
- Compare share dealing platforms
- Is Athersys stock a buy or sell?
- Athersys performance over time
- Can I short Athersys shares?
- Athersys's financials
- How volatile are Athersys shares?
- Does Athersys pay a dividend?
- Have Athersys shares ever split?
- Other common questions
How has Coronavirus impacted Athersys's stock price?
Since the stock market crash in March caused by coronavirus, Athersys's stock price has had significant positive movement.
Its last market close was $1.67, which is 23.35% up on its pre-crash value of $1.28 and 47.79% up on the lowest point reached during the March crash when the stocks fell as low as $1.13.
If you had bought $1,000 worth of Athersys stocks at the start of February 2020, those stocks would have been worth $1,433.82 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,227.93.
Athersys stock priceUse our graph to track the performance of ATHX stocks over time.
Athersys stocks at a glance
|Latest market close||$1.67|
|52-week range||$1.35 - $3.03|
|50-day moving average||$1.49|
|200-day moving average||$1.8042|
|Wall St. target price||$5.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.306|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Athersys stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Athersys price performance over time
|1 month (2021-07-02)||13.61%|
|3 months (2021-05-04)||4.37%|
|Revenue TTM||USD$1.4 million|
|Gross profit TTM||USD$-61,554,000|
|Return on assets TTM||-100.07%|
|Return on equity TTM||-310.59%|
|Market capitalisation||USD$357.5 million|
TTM: trailing 12 months
How to short and sell Athersys stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ATHX.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 17.3 million Athersys stocks held short by investors – that's known as Athersys's "short interest". This figure is 1.4% down from 17.6 million last month.
There are a few different ways that this level of interest in shorting Athersys stocks can be evaluated.
Athersys's "short interest ratio" (SIR)
Athersys's "short interest ratio" (SIR) is the quantity of Athersys stocks currently shorted divided by the average quantity of Athersys stocks traded daily (recently around 2.5 million). Athersys's SIR currently stands at 6.83. In other words for every 100,000 Athersys stocks traded daily on the market, roughly 6830 stocks are currently held short.
However Athersys's short interest can also be evaluated against the total number of Athersys stocks, or, against the total number of tradable Athersys stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Athersys's short interest could be expressed as 0.08% of the outstanding stocks (for every 100,000 Athersys stocks in existence, roughly 80 stocks are currently held short) or 0.0852% of the tradable stocks (for every 100,000 tradable Athersys stocks, roughly 85 stocks are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the stock price, with fewer people currently willing to bet against Athersys.
Find out more about how you can short Athersys stock.
Athersys stock dividends
We're not expecting Athersys to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Athersys stocks ever split?
Athersys stocks were split on 4 June 2007. This wouldn't directly have changed the overall worth of your Athersys stocks – just the quantity. However, indirectly, the new INF% higher stock price could have impacted the market appetite for Athersys stocks which in turn could have impacted Athersys's stock price.
Athersys stock price volatility
Over the last 12 months, Athersys's stocks have ranged in value from as little as $1.35 up to $3.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Athersys's is -1.7008. This would suggest that Athersys's stocks have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Athersys has bucked the trend.
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as in Phase II clinical study for the treatment of patients with acute myocardial infarction, and has completed Phase I clinical study for the treatment of patients suffering from leukemia or various other blood-borne cancers. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.
Stocks similar to Athersys
Athersys in the news
Longeveron's Novel Therapy Looks to Tackle COVID-19, Flu-Related ARDS
Longeveron's Novel Therapy Looks to Tackle COVID-19, Flu-Related ARDS
Athersys: Subgroup Analysis As A Masterstroke
Frequently asked questions
More guides on Finder
How to buy Wheels Up (UP) stock in Canada when it goes public
Everything we know about the Wheels Up IPO, plus information on how to buy in.
How to invest $1 million
Here are the top 5 ways you should invest $1 million.
How to buy Brookfield Asset Management Reinsurance Partners Ltd (BAMR) stock in Canada when it goes public
Everything we know about the Brookfield Asset Management Reinsurance Partners Ltd IPO, plus information on how to buy in.
How to buy Traeger (COOK) stock in Canada
Everything we know about the Traeger IPO, plus information on how to buy in.
How to buy Teads (TEAD) stock in Canada when it goes public
Everything we know about the Teads IPO, plus information on how to buy in.
How to buy Snap One Holdings Corp (SNPO) stock in Canada
Everything we know about the Snap One Holdings Corp IPO, plus information on how to buy in.
How to buy Riskified (RSKD) stock in Canada
Everything we know about the Riskified IPO, plus information on how to buy in.
How to buy Preston Hollow Community Capital (PHCC) stock in Canada when it goes public
Everything we know about the Preston Hollow Community Capital IPO, plus information on how to buy in.
How to buy PowerSchool Holdings (PWSC) stock in Canada
Everything we know about the PowerSchool Holdings IPO, plus information on how to buy in.
How to buy MeridianLink (MLNK) stock in Canada
Everything we know about the MeridianLink IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.